Already more than 50% of U.S. hospitals use Apple’s healthkit research app to treat serious and chronic health issues. The acquisition of Gliimpse could further strengthen Apple’s business in this segment.
Going by the report from Fast Company, Apple is said to have purchased a startup that specializes in helping users collect and personalize their health records.
It appears, that Apple had acquired this company a year earlier, but was coy as usual.
“Apple buys smaller technology companies from time to time, and we generally do not discuss our purpose or plans,” said a spokesperson from Apple.
It is likely that this company will be integrated into Apple’s HealthKit research app in order to help doctors improve treatments for chronic ailments.
According to Anil Sethi, founder of Gliimpse, “there’s no single electronic health record that all physicians use … Worse, there isn’t even a common file format across 1,000+ systems.”
The app is primarily targeted at patients who have complex health records, including those who suffer from chronic illnesses such as cancer, diabetes, and heart problems.
Significantly, Apple’s HealthKit is used by more than 50% of hospitals in the US to monitor patients with serious health issues.
Gliimpse’s aim is to help researchers conduct trials to gauge the effectiveness of treatments for chronic and serious diseases. It does so by collecting confidential patient data with “rigorous technical security”.
Given Apple’s involvement in healthcare, the deal makes sense. However, it could be a while before Apple capitalizes on this acquisition. It would be interesting to see how Apple brings it into its fold.